FDA Inspection
National Cancer Institute (NCI)FDA Inspection 992601 - National Cancer Institute (NCI) - November 15, 2016
Record Details
This FDA Inspection record concerns National Cancer Institute (NCI), with an inspection on November 15, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- November 15, 2016
- Product Type
- Drugs
View Company Profile
ID · faed2d7a-8ad2-4eb1-9949-f6ff5b586e83
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 992601
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.50General responsibilities of sponsors
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.